Supercharged Peptides for Inner Ear Cell Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regenerating hair cells in the inner ear are limited, as transdifferentiation of supporting cells diminishes the existing population, and overexpression of Atoh1 in aged ears or flat epithelium is not sufficient to induce hair cells, while genetic deafness treatments are challenging due to hair cell and supporting cell degeneration before birth, leading to a need for regenerating hair and supporting cells postnatally to restore hearing and vestibular function.
Innovation Solution
The use of therapeutic compositions that activate Myc and Notch in inner ear cells to induce proliferation and transdifferentiation of hair and supporting cells, with the subsequent inhibition of Myc and Notch to promote differentiation into hair cells, and the activation of Atoh1 to induce supporting cells to become hair cells, utilizing supercharged proteins and peptides linked to anionic molecules for efficient delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If transdifferentiation of supporting cells to hair cells is induced by Atoh1 overexpression, then new hair cells are generated, but the existing population of supporting cells is diminished which impairs inner ear function
Solution Approach 1:
The invention segments the regeneration process into distinct phases: first inducing cell cycle reentry in supporting cells to expand the cell pool, then inducing transdifferentiation to hair cells. This temporal segmentation prevents depletion of supporting cells by ensuring sufficient cell proliferation before differentiation occurs.
Solution Approach 2:
The invention applies preliminary action by first activating cell cycle reentry pathways (using CDK4/6 inhibitors or other mechanisms) to expand the supporting cell population before inducing transdifferentiation. This preliminary proliferation ensures that the supporting cell reservoir is sufficient to provide cells for hair cell regeneration without compromising existing inner ear function.
2Productivity
If cell cycle reentry is induced in adult inner ear cells, then proliferation may occur, but similar manipulations have not successfully induced cell cycle reentry in the adult inner ear
Solution Approach 1:
The invention changes key parameters of cell cycle regulation in adult inner ear cells by using specific inhibitors (CDK4/6 inhibitors, p27kip1 modulation) to override age-related cell cycle arrest. This parameter change enables proliferation in adult cells that would otherwise remain quiescent, achieving productivity without compromising reliability.
3Reliability
If genetic deafness is treated by correcting mutations in hair cells and supporting cells, then hereditary deafness may be corrected, but affected cells have already died or are severely degenerated by birth making intervention difficult
Solution Approach 1:
The invention applies preliminary action by establishing a postnatal intervention window through induced cell cycle reentry and proliferation. By creating a period of active cell division and regeneration after birth, the invention opens a time window for genetic correction therapies that would otherwise be unavailable, as affected cells normally die before birth or early in development.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively regenerates hair and supporting cells, restoring or improving hearing and vestibular function by promoting cell cycle re-entry and differentiation, addressing the limitations of existing regeneration methods and enabling postnatal regeneration of critical inner ear cells.
Implementation Method 1
utilizing supercharged proteins and peptides linked to anionic molecules for efficient delivery
Data Source
AI summary
Compositions and provided to induce cells of the inner ear to renter the cell cycle and to proliferate. In particular, hair cells are induced to proliferate by administration of a composition which activates the Myc and Notch. Supporting cells are induced to transdifferentiate to hair cells by inhibition of Myc and Notch activity or the activation of Atoh1. Methods of treatment include the intracellular delivery of these molecules to a specific therapeutic target.